{"nct_id":"NCT05571969","title":"Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors","status":"SUSPENDED","status_verified_date":"2025-05","start_date":"2023-02-20","start_date_type":"ACTUAL","primary_completion_date":"2024-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2025-12","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ALLR"]}